The PIONEER study (NCT01185314) is a large prospective molecular epidemiology study in Asian patients with newly diagnosed advanced lung adenocarcinoma, aiming to assess their EGFR mutation status [13]. This evidence concerns the gene EGFR and lung adenocarcinoma.